Dr. Hillel Adesnik (University of California, Berkeley) 1DP2NS087725-01
For studies on cortical function and neurological disorders.
Dr. Samantha Brugmann (Cincinnati Children’s Hospital Medical Center) 1R01DE023804-01
For studies on the developmental processes essential to craniofacial development.
Dr. Namandje Bumpus (Johns Hopkins University) 1R01GM103853-01
For studies to investigate the mechanisms underlying the hepatotoxicity of antiretroviral drugs.
Dr. Kafui Dzirasa (Duke University) 1R01MH099192-01
For studies of large scale neural network interactions that may shed light on the pathophysiology of affective disorders.
Dr. Camilla Forsberg (University of California, Santa Cruz) 1R01DK100917-01
For studies to understand the mechanisms that regulate stem cell fate decisions.
Dr. Tina Goldstein (University of Pittsburgh) 1R01MH100056-01A
For studies to develop and test therapies for adolescents with bipolar disorder to target mood symptoms and suicidality.
Dr. Viviana Gradinaru (California Institute of Technology) 1DP2NS087949-01
For studies on the architecture of neuron-communication in the brain.
Dr. Jordan J. Green (Johns Hopkins University) 1R01EB016721-01
For studies to develop nanoparticles for delivery of therapeutic DNA to brain cancer cells.
Dr. Katie Kindt (National Institute on Deafness and Other Communication Disorders) 1ZIADC000085-01
For studies on disorders in mechanosensation, such as hearing, balance, and touch.
Dr. Andre Larochelle (National Heart, Lung, and Blood Institute) 1ZIAHL006172-01
For studies on regenerative therapies for inherited blood disorders.
Dr. Jennifer Lorvick (Research Triangle Institute International) 1R01MD007679-01
For studies to understand how criminal justice involvement contributes to health disparities among illicit drug using African American women.
Dr. Courtney Miller (The Scripps Research Institute) 1R01DA034116-01A1
For studies on the prevention of substance abuse relapse triggered by drug-associated memory.
Dr. Kiran Musunuru (Harvard University) 1R01HL118744-01
For studies to understand the genetics of cardiovascular disease.
Dr. David J. Pagliarini (University of Wisconsin- Madison) 1R01DK098672-01
For studies to examine the mitochondrial proteome during the development of obesity and diabetes.
Dr. Sachin Patel (Vanderbilt University) 1R01MH100096-01
For studies on the treatment of anxiety and post-traumatic stress disorders.
Dr. Amy Ralston (Michigan State University) 1R01GM104009-01A1
For studies to reveal insight into mammalian early development and stem cell establishment.
Dr. Ervin Sejdic (University of Pittsburgh) 1R01HD074819-01
For studies to address a significant problem in those suffering from stroke, namely Dysphagia (or swallowing impairment).
Dr. Elizabeth Skidmore (University of Pittsburgh) 1R01HD074693-01A1
For studies to examine the influences of cognitive and affective impairments on neurorehabilitation outcomes.
Dr. Kay Maxine Tye (Massachusetts Institute of Technology) 1DP2DK102256-01
For studies to develop and apply methods to decipher and manipulate the neural circuitry underlying compulsive sugar intake to ameliorate behaviors leading to obesity.
Dr. Muhammad Walji (The University of Texas Health Science Center Houston) 1R01DE022628-01A1
For studies to improve the usability of electronic health records to mitigate critical use errors that may harm patients.